Severity of coronary artery disease affects prognosis of patients with peripheral artery disease

Takayuki Ishihara1, Osamu Iida, Atsushi Tosaka

  • 1Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Japan. t.ishihara31@gmail.com

Angiology
|July 10, 2012
PubMed

Insights

Coronary artery disease (CAD) severity significantly impacts peripheral artery disease (PAD) patient outcomes. Patients with triple-vessel disease faced higher risks of death, major adverse cardiac events, and amputation compared to those with no or intermediate CAD.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Interventional Cardiology

Background:

  • Prognostic impact of coronary artery disease (CAD) severity in peripheral artery disease (PAD) patients remains unclear.
  • PAD patients often have coexisting CAD, influencing their overall health outcomes.
  • Understanding this relationship is crucial for risk stratification and treatment planning.

Purpose of the Study:

  • To investigate whether the severity of coronary artery disease (CAD) influences the prognosis of patients with symptomatic peripheral artery disease (PAD).
  • To compare clinical outcomes across different CAD severity groups in PAD patients undergoing revascularization.

Main Methods:

  • Retrospective, multicenter analysis of 537 consecutive patients with symptomatic PAD.
  • Patients underwent peripheral artery revascularization and coronary angiography (CAG) prior to revascularization.
  • Classification into three groups based on CAG: no-CAD, intermediate CAD (1-2 diseased vessels), and triple-vessel disease (TVD).

Main Results:

  • The study included 204 patients in the no-CAD group, 268 in the intermediate CAD group, and 65 in the TVD group.
  • Mean follow-up was 952 days.
  • Freedom from adverse outcomes decreased significantly with increasing CAD severity: all-cause death (86% vs 77% vs 65%), MACE (95% vs 87% vs 78%), and amputation (96% vs 92% vs 83%).

Conclusions:

  • The severity of coronary artery disease (CAD) significantly affects the prognosis of patients with peripheral artery disease (PAD).
  • Triple-vessel disease (TVD) is associated with poorer outcomes, including higher rates of mortality, MACE, and amputation.
  • Risk stratification and tailored management strategies are warranted for PAD patients based on their CAD severity.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...